In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir

J Antimicrob Chemother. 2021 Nov 12;76(12):3310-3312. doi: 10.1093/jac/dkab309.

Authors

Francesco Saladini¹, Alessia Giannini¹, Federica Giammarino¹, Adele Boccuto¹, Filippo Dragoni¹, Ilaria Vicenti¹, Maurizio Zazzi¹

Affiliation

¹ Department of Medical Biotechnologies, University of Siena, Siena, Italy.

PMID: 34402509
DOI: 10.1093/jac/dkab309

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-HIV Agents* / pharmacology
Anti-HIV Agents* / therapeutic use
HIV Infections* / drug therapy
HIV-1*
Humans
Organophosphates / therapeutic use
Phylogeny
Piperazines / therapeutic use

Substances

Anti-HIV Agents
Organophosphates
Piperazines
fostemsavir